Pfizer (PFE) Stock on December 2, 2025: Price, Metsera Deal, New FDA Risks and 2026 Outlook
As of late trading on Tuesday, December 2, 2025, Pfizer (NYSE: PFE) shares change hands around $25.10, down roughly 0.7% on the day and sitting in the middle of their 52‑week range of $20.92–$27.69.Yahoo Finance+1 The stock carries a dividend yield close to 7%, reflecting a generous payout but also lingering skepticism about the pharma giant’s growth post‑COVID.Pfizer+1 Today’s price is being shaped by a dense mix of headlines: a fresh FDA push to tighten vaccine oversight, a legal setback for Pfizer’s Seagen unit, the completion of a $10 billion obesity-drug acquisition, and earlier this quarter, upgraded 2025 profit guidance and new oncology approvals.Pfizer+4Investopedia+4Reuters+4 Below is